These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1672622

  • 1. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L, Jardillier JC, Ordentlich P.
    Cancer Res; 1991 Apr 15; 51(8):1996-2001. PubMed ID: 1672622
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB, Beck WT, Trent JM.
    Cancer Res; 1988 Jan 15; 48(2):393-8. PubMed ID: 2891436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.
    Cass CE, Janowska-Wieczorek A, Lynch MA, Sheinin H, Hindenburg AA, Beck WT.
    Cancer Res; 1989 Nov 01; 49(21):5798-804. PubMed ID: 2790792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations of vinblastine influx in multidrug-resistant lymphoblastic leukaemic CEM cells.
    Colin M, Madoulet C, Warren L, Jardillier JC.
    Anticancer Res; 1996 Nov 01; 16(1):407-12. PubMed ID: 8615645
    [Abstract] [Full Text] [Related]

  • 10. Increased accumulation of drugs in multidrug-resistant cells induced by liposomes.
    Warren L, Jardillier JC, Malarska A, Akeli MG.
    Cancer Res; 1992 Jun 01; 52(11):3241-5. PubMed ID: 1591733
    [Abstract] [Full Text] [Related]

  • 11. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT, Sharma R, Grady JJ, Awasthi S.
    Drug Metab Dispos; 2001 Feb 01; 29(2):103-10. PubMed ID: 11159798
    [Abstract] [Full Text] [Related]

  • 12. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M, Morris MB, Roufogalis BD.
    Br J Cancer; 2001 Dec 14; 85(12):1998-2003. PubMed ID: 11747345
    [Abstract] [Full Text] [Related]

  • 13. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
    Kavallaris M, Madafiglio J, Norris MD, Haber M.
    Biochem Biophys Res Commun; 1993 Jan 15; 190(1):79-85. PubMed ID: 8093660
    [Abstract] [Full Text] [Related]

  • 14. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.
    Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW.
    Cancer Res; 1989 Oct 01; 49(19):5281-7. PubMed ID: 2569932
    [Abstract] [Full Text] [Related]

  • 15. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
    Bobichon H, Colin M, Depierreux C, Liautaud-Roger F, Jardillier JC.
    J Exp Ther Oncol; 1996 Jan 01; 1(1):49-61. PubMed ID: 9414388
    [Abstract] [Full Text] [Related]

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
    Shu Y, Liu H.
    Biochem Cell Biol; 2007 Oct 01; 85(5):638-46. PubMed ID: 17901905
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S, Bianchi F, Bernardini N, Mattii L, Dolfi A, Lupetti M, Petrini M.
    Cell Mol Biol (Noisy-le-grand); 1993 Jul 01; 39(5):543-51. PubMed ID: 8104068
    [Abstract] [Full Text] [Related]

  • 19. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB, Rittmann-Grauer L, O'Brien JP, Safa AR.
    Cancer Res; 1989 Jun 15; 49(12):3209-14. PubMed ID: 2566379
    [Abstract] [Full Text] [Related]

  • 20. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K, Sato W, Yamazaki A, Tsukahara S, Tsuruo T.
    Anticancer Res; 1991 Jun 15; 11(3):1301-4. PubMed ID: 1909515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.